Recombinant IFN-beta-1a from Ares-Serono reduces relapses, delays progression in MS Dec. 2, 1997 No Comments
Biological profile of the potent, selective dopamine D4 antagonist L-745870 Nov. 28, 1997 No Comments
RSS